General Constitutional

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC5-26

DiraChart Clinical Reference
Protected section 26 of 26
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 26 of 26PreviousDocument Menu

19. Sources and clinical references

MASTER-level citations, current as of the version date. Companies and agencies may append payer-specific requirements (MAC LCDs, ADR criteria, local notification parameters) as overlays without altering the MASTER version.

  • CMS Medicare Benefit Policy Manual (Pub. 100-02), Chapter 7 — Home Health Services. Skilled nursing care (§ 40.1), observation and assessment (§ 40.1.2.1), teaching and training (§ 40.1.2.3), management and evaluation of the plan of care (§ 40.1.2.2), homebound (§ 30.1), and reasonable and necessary services (§ 20.1.2).
  • 42 CFR Part 484 — Conditions of Participation for Home Health Agencies. Comprehensive assessment (§ 484.55) and care planning and coordination of services (§ 484.60).
  • CMS OASIS-E2 Guidance Manual, effective April 1, 2026. Outcome and Assessment Information Set used for the comprehensive assessment and quality reporting.
  • Community Health Accreditation Partner (CHAP) Standards of Excellence for Home Health. [Insert the exact standard title, version, section, and effective date per the edition held by the agency.]
  • Sepsis recognition references. The constitutional cluster of fever, tachycardia, tachypnea, and altered mental status is interpreted with the vital-sign set; agencies should apply their adopted early-warning and sepsis-screening criteria and local escalation parameters.

Usage note: Every narrative and smart phrase in this module is a structured example to be edited to reflect what was actually assessed and the patient's specific orders. Documentation must reflect the real visit; do not copy unchanged.

Section NavigationPart 26 of 26PreviousDocument Menu